CorMedix (id:6706 CRMD)
9.96 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/23/2024 10:29:59 PM)
Exchange closed, opens in 1 day 10 hours
-3.68 USD (-3.68%)
-4.00 USD (-4.00%)
-1.87 USD (-1.87%)
92.28 USD (92.28%)
162.11 USD (162.11%)
63.82 USD (63.82%)
32.80 USD (32.80%)
-37.75 USD (-37.75%)
About CorMedix
Market Capitalization 626.80M
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
| Headquarters (address) |
300 Connell Drive Berkeley Heights 07922 NJ United States |
| Phone | 908 517 9500 |
| Website | https://www.cormedix.com |
| Employees | 82 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | CRMD |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 2.89 - 13.85 |
| Market Capitalization | 626.80M |
| P/E trailing | -10.96 |
| P/E forward | 21.52 |
| Price/Sale | 51.12 |
| Price/Book | 10.19 |
| Beta | 1.58 |
| EPS | -0.800 |
| EPS United States (ID:6, base:3403) | 24.22 |